204 related articles for article (PubMed ID: 23349954)
1. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study.
Kanoksil M; Jatapai A; Peacock SJ; Limmathurotsakul D
PLoS One; 2013; 8(1):e54714. PubMed ID: 23349954
[TBL] [Abstract][Full Text] [Related]
2. Increasing incidence of hospital-acquired and healthcare-associated bacteremia in northeast Thailand: a multicenter surveillance study.
Hongsuwan M; Srisamang P; Kanoksil M; Luangasanatip N; Jatapai A; Day NP; Peacock SJ; Cooper BS; Limmathurotsakul D
PLoS One; 2014; 9(10):e109324. PubMed ID: 25310563
[TBL] [Abstract][Full Text] [Related]
3. Comparative clinical characteristics and outcomes of patients with community acquired bacteremia caused by Escherichia coli, Burkholderia pseudomallei and Staphylococcus aureus: A prospective observational study (Ubon-sepsis).
Somayaji R; Hantrakun V; Teparrukkul P; Wongsuvan G; Rudd KE; Day NPJ; West TE; Limmathurotsakul D
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009704. PubMed ID: 34478439
[TBL] [Abstract][Full Text] [Related]
4. High Burden of Extended-Spectrum β-Lactamase-Producing
Sawatwong P; Sapchookul P; Whistler T; Gregory CJ; Sangwichian O; Makprasert S; Jorakate P; Srisaengchai P; Thamthitiwat S; Promkong C; Nanvatthanachod P; Vanaporn M; Rhodes J
Am J Trop Med Hyg; 2019 Apr; 100(4):943-951. PubMed ID: 30793684
[TBL] [Abstract][Full Text] [Related]
5. Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States.
Thaden JT; Fowler VG; Sexton DJ; Anderson DJ
Infect Control Hosp Epidemiol; 2016 Jan; 37(1):49-54. PubMed ID: 26458226
[TBL] [Abstract][Full Text] [Related]
6. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia.
Hounsom L; Grayson K; Melzer M
Postgrad Med J; 2011 Nov; 87(1033):757-62. PubMed ID: 21798969
[TBL] [Abstract][Full Text] [Related]
7. EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
Pornsinchai P; Chongtrakool P; Diraphat P; Siripanichgon K; Malathum K
Southeast Asian J Trop Med Public Health; 2015 Jan; 46(1):51-62. PubMed ID: 26513905
[TBL] [Abstract][Full Text] [Related]
8. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
[TBL] [Abstract][Full Text] [Related]
9. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.
Khanfar HS; Bindayna KM; Senok AC; Botta GA
J Infect Dev Ctries; 2009 May; 3(4):295-9. PubMed ID: 19759493
[TBL] [Abstract][Full Text] [Related]
10. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
Sethaphanich N; Santanirand P; Rattanasiri S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
Pediatr Int; 2016 May; 58(5):338-46. PubMed ID: 26513341
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
Wang Y; Zhang Q; Jin Y; Jin X; Yu J; Wang K
Braz J Microbiol; 2019 Jul; 50(3):669-675. PubMed ID: 30972583
[TBL] [Abstract][Full Text] [Related]
12. Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study.
Peralta G; Lamelo M; Alvarez-García P; Velasco M; Delgado A; Horcajada JP; Montero M; Roiz MP; Fariñas MC; Alonso J; Martínez LM; Gutiérrez-Macías A; Alava JA; Rodríguez A; Fleites A; Navarro V; Sirvent E; Capdevila JA;
BMC Infect Dis; 2012 Oct; 12():245. PubMed ID: 23038999
[TBL] [Abstract][Full Text] [Related]
13. Incidence of community-onset extended-spectrum β-lactamase-producing
Richelsen R; Smit J; Anru PL; Schønheyder HC; Nielsen H
Infect Dis (Lond); 2020 Aug; 52(8):547-556. PubMed ID: 32401562
[No Abstract] [Full Text] [Related]
14. Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London.
Skippen I; Shemko M; Turton J; Kaufmann ME; Palmer C; Shetty N
J Hosp Infect; 2006 Oct; 64(2):115-23. PubMed ID: 16859810
[TBL] [Abstract][Full Text] [Related]
15. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
Hernández JR; Pascual A; Cantón R; Martínez-Martínez L;
Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):77-82. PubMed ID: 12586030
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes.
Apisarnthanarak A; Kiratisin P; Mundy LM
Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1026-34. PubMed ID: 18947321
[TBL] [Abstract][Full Text] [Related]
17. Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Apisarnthanarak A; Kiratisin P; Mundy LM
Infect Control Hosp Epidemiol; 2008 Jul; 29(7):671-4. PubMed ID: 18624669
[TBL] [Abstract][Full Text] [Related]
18. [Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms].
Ferrández O; Grau S; Saballs P; Luque S; Terradas R; Salas E
Rev Clin Esp; 2011 Mar; 211(3):119-26. PubMed ID: 21371702
[TBL] [Abstract][Full Text] [Related]
19. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome.
Kim YK; Pai H; Lee HJ; Park SE; Choi EH; Kim J; Kim JH; Kim EC
Antimicrob Agents Chemother; 2002 May; 46(5):1481-91. PubMed ID: 11959586
[TBL] [Abstract][Full Text] [Related]
20. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]